JENNIFER DEMBER: Open Payments
NPI 1235890716 · HOLMDEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 81 payments from 17 companies in 2025. Trend: 2023 $1,331 · 2024 $1,698 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $413 |
| Lilly USA, LLC | 14 | $203 |
| ABBVIE INC. | 6 | $103 |
| Exact Sciences Corporation | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| Lundbeck LLC | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| Dexcom, Inc. | 2 | $44 |
Products named: Wegovy, REXULTI, Ozempic, Cologuard Collection Kit, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, UBRELVY.
Industry payments across NJ — which companies pay providers there.
